Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Diabetologia. 2020 Sep;63(9):1718-1735. doi: 10.1007/s00125-020-05199-0. Epub 2020 Jul 6.
AIMS/HYPOTHESIS: We examined all-cause mortality trends in people with diabetes and compared them with trends among people without diabetes.
MEDLINE, EMBASE and CINAHL databases were searched for observational studies published from 1980 to 2019 reporting all-cause mortality rates across ≥2 time periods in people with diabetes. Mortality trends were examined by ethnicity, age and sex within comparable calendar periods.
Of 30,295 abstracts screened, 35 studies were included, providing data on 69 separate ethnic-specific or sex-specific populations with diabetes since 1970. Overall, 43% (3/7), 53% (10/19) and 74% (32/43) of the populations studied had decreasing trends in all-cause mortality rates in people with diabetes in 1970-1989, 1990-1999 and 2000-2016, respectively. In 1990-1999 and 2000-2016, mortality rates declined in 75% (9/12) and 78% (28/36) of predominantly Europid populations, and in 14% (1/7) and 57% (4/7) of non-Europid populations, respectively. In 2000-2016, mortality rates declined in 33% (4/12), 65% (11/17), 88% (7/8) and 76% (16/21) of populations aged <40, 40-54, 55-69 and ≥70 years, respectively. Among the 33 populations with separate mortality data for those with and without diabetes, 60% (6/10) of the populations with diabetes in 1990-1999 and 58% (11/19) in 2000-2016 had an annual reduction in mortality rates that was similar to or greater than in those without diabetes.
CONCLUSIONS/INTERPRETATION: All-cause mortality has declined in the majority of predominantly Europid populations with diabetes since 2000, and the magnitude of annual mortality reduction matched or exceeded that observed in people without diabetes in nearly 60% of populations. Patterns of diabetes mortality remain uncertain in younger age groups and non-Europid populations.
PROSPERO registration ID CRD42019095974. Graphical abstract.
目的/假设:我们研究了糖尿病患者的全因死亡率趋势,并将其与非糖尿病患者的趋势进行了比较。
检索了 1980 年至 2019 年发表的观察性研究,这些研究报告了糖尿病患者在至少两个时间段内的全因死亡率。在可比的日历时期内,按种族、年龄和性别检查死亡率趋势。
在筛选出的 30295 篇摘要中,有 35 项研究被纳入,提供了自 1970 年以来 69 个特定种族或特定性别的具有糖尿病的人群的 69 项独立数据。总体而言,1970-1989 年、1990-1999 年和 2000-2016 年,分别有 43%(3/7)、53%(10/19)和 74%(32/43)的人群中糖尿病患者的全因死亡率呈下降趋势。在 1990-1999 年和 2000-2016 年,在主要为欧洲裔的人群中,死亡率分别下降了 75%(9/12)和 78%(28/36),而非欧洲裔人群中,死亡率分别下降了 14%(1/7)和 57%(4/7)。在 2000-2016 年,年龄<40 岁、40-54 岁、55-69 岁和≥70 岁的人群中,死亡率分别下降了 33%(4/12)、65%(11/17)、88%(7/8)和 76%(16/21)。在有糖尿病和无糖尿病单独死亡率数据的 33 个人群中,1990-1999 年有 60%(6/10)的糖尿病人群和 2000-2016 年有 58%(11/19)的糖尿病人群的死亡率年降幅与无糖尿病人群相似或更大。
结论/解释:自 2000 年以来,大多数主要为欧洲裔的糖尿病患者的全因死亡率有所下降,在近 60%的人群中,死亡率的年降幅与无糖尿病人群相当或更大。在年轻人群和非欧洲裔人群中,糖尿病死亡率的模式仍不确定。
PROSPERO 注册号 CRD42019095974. 图表摘要。